Kathiawad Today

Peanut Allergy Market

DelveInsight’s “Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as the Peanut Allergy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Peanut Allergy market report provides current treatment practices, emerging drugs, Peanut Allergy market share of the individual therapies, current and forecasted Peanut Allergy market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Peanut Allergy treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Peanut Allergy market.

Some of the key facts of the Peanut Allergy Market:

• Among EU5 countries, Germany had the highest number of diagnosed prevalent cases of peanut allergy (1,017,263 cases) in 2020. As per DelveInsight’s estimates, these are expected to rise by 2030. 

• In the United States, peanut allergy cases were higher in males than in females. In 2018 there were 3,631,846 males and 2,401,121 females affected with peanut allergy. DelveInsight estimates that the number will increase by 2030.

• DelveInsight’s assessments show that in 2020, there were 92,558 mild-to-moderate cases and 194,888 severe cases of peanut allergy in Japan, which are expected to change in the forecast period.  

Got queries? Click here to know more about the Peanut Allergy market Landscape

Peanut Allergy Overview

Peanut allergy accounts for the majority of severe food-related allergic reactions. It tends to present early in life, and affected individuals generally do not outgrow it. In highly sensitized people, trace quantities can induce an allergic reaction. The major peanut antigens identified by the specific antibodies response include Ara h 1, h 2, and h 3. The severity of reactions to peanuts can vary. Mild reactions are most common and consist of hives, abdominal pain, and vomiting. Anaphylaxis is the most severe reaction and can be life-threatening. It can involve difficulty breathing, throat swelling, or a drop in blood pressure. Symptoms usually develop within minutes after ingestion of even a trace amount of peanut and may involve cutaneous, cardiovascular, gastrointestinal, genitourinary, and/ or respiratory systems. The primary care of treatment includes antihistamines and injectable epinephrine, prescribed to patients with mild and moderate to severe peanut allergy cases. However, these medications do not treat anaphylaxis; rather, they are adjunctive therapies for anaphylaxis management. 

Peanut Allergy Epidemiology Insights

• The total 7MM diagnosed prevalent cases of peanut allergy in 2020 were 10,578,543, out of which the highest cases were observed in the United States. The EU5 countries accounted for 4,175,185 cases, whereas Japan had 287,446 cases in 2020. The total diagnosed prevalent cases in the 7MM were calculated by adding the cases in individual countries. 

• In 2020, there were 6,115,912 diagnosed prevalent cases of peanut allergy in the United States.

• DelveInsight’s assessments show that in 2020, there were 709,547 cases of peanut allergy in  4–11 years age group, 544,205 cases in the 12–17 years age group, and 343,613 cases in 1–3 years age group in the United States.

Peanut Allergy Epidemiology Segmentation

• Total Peanut Allergy diagnosed cases

• Total  Peanut Allergy gender specific cases

• Total Peanut Allergy age specific cases

• Total Peanut Allergy severity specific cases 

Peanut Allergy Market Outlook 

The Peanut Allergy market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Peanut Allergy market trends by analyzing the impact of current Peanut Allergy therapies on the market, unmet needs, drivers and barriers, and demand for better technology.This segment gives a thorough detail of Peanut Allergy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Peanut Allergy market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Peanut Allergy market in 7MM is expected to witness a major change in the study period 2019-2032.

 Learn more by requesting for sample @ Peanut Allergy Market

Peanut Allergy Key Companies 

• DBV Technologies

• Sanofi

• Camallergy

• Vedanta Biosciences

• And many more

Peanut Allergy  Therapies

• Viaskin Peanut

• Dupixent

• CA002

• VE416

• And many more

Market Drivers 

• Increasing prevalence

• Uptake of immunotherapy assets

• Development of concise clinical  guidelines

Market Barriers 

• Limited patient awareness and established treatment protocols

• Poor understanding of disease etiology

• Gap in real world practice and clinical trials

Table of Contents

•  Key Insights 

•  Report Introduction 

•  Executive Summary of Peanut Allergy 

•  Disease Background and Overview

•  Epidemiology and patient population

•  The United States 

•  EU 5

•  Peanut Allergy   Emerging Therapies

•  Peanut Allergy Market Outlook

•  Market Access and Reimbursement of Therapies

•  Market Drivers 

•  Market Barriers 

•  Appendix

•  Peanut Allergy Report Methodology

•  DelveInsight Capabilities

•  Disclaimer

Click here to read more about Peanut Allergy Market

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Adya Kaul
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/